Epigenetic down-regulation of BK(Ca) channel by miR-181a contributes to the fetal and neonatal nicotine-mediated exaggerated coronary vascular tone in adult life

miR-181a通过表观遗传途径下调BK(Ca)通道,导致胎儿和新生儿时期尼古丁介导的成年期冠状动脉血管张力过度增强。

阅读:1

Abstract

BACKGROUND: Fetal origin of adult cardiovascular disease is one of the most pressing public concerns and economic problem in modern life. Maternal cigarette smoking/nicotine abuse increases the risk of cardiovascular disease in offspring. However, the underlying mechanisms and theranostics remain unclear. We hypothesized that fetal and neonatal nicotine exposure enhances microRNA-181a (miR-181a) which targets large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels, resulting in increased coronary vascular tone in adult offspring. METHODS: Nicotine or saline was administered to pregnant rats via subcutaneous osmotic minipumps from gestational day 4 until postnatal day 10. Experiments were conducted in adult (~6 month old) male offspring. RESULTS: Nicotine enhanced pressure-induced coronary vascular tone, which was abrogated by BK(Ca) channel blocker. Nicotine selectively attenuated coronary BK(Ca) β1 but not α subunit expression. Functionally, nicotine suppressed BK(Ca) current density and inhibited BK(Ca) activator NS1619-induced coronary relaxations. Furthermore, activation of BK(Ca) increased coronary flow and improved heart ischemia/reperfusion-induced infarction. Nicotine selectively enhanced miR-181a expression. MiR-181a mimic inhibited BK(Ca) β1 expression/channel current and decreased NS1619-induced coronary relaxation. Antioxidant eliminated the difference of BK(Ca) current density between the saline and nicotine-treated groups and partially restored NS1619-induced relaxation in nicotine group. MiR-181a antisense decreased vascular tone and eliminated the differences between nicotine exposed and control groups. CONCLUSION: Fetal and neonatal nicotine exposure-mediated miR-181a overexpression plays an important role in nicotine-enhanced coronary vascular tone via epigenetic down-regulation of BK(ca) channel mechanism, which provides a potentially novel therapeutic molecular target of miR-181a/BK(ca) channels for the treatment of coronary heart ischemic disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。